ACET

ADICET BIO INC

ACET·007002207·US·Common Stock·Healthcare - Biotechnology-Activist

ACET (ADICET BIO INC) is held by 31 institutional investors as of Q1 2026. Largest holders: RA CAPITAL MANAGEMENT, L.P. ($8.1M), FRANKLIN RESOURCES INC ($4.3M), CITADEL ADVISORS LLC ($2.6M). Net institutional sentiment: Mixed.

31
Holders
(1 Elite)
$28.8M
Total Value
67% (27)
Consensus
18 buying - 9 selling
13F: Insider & Congress:
ACETSmart Money Verdict
View all
Held by 31 funds
1 elite
Who's Trading
ActivistWoodline Partners LPWoodline Partners LP3.3%May 15, 2026
InsiderRLRA CAPITAL MANAGEMENT, L.P.Other 250K shApr 27, 2026
ActivistRA Capital Management, L.P.RA Capital Management, L.P.12.3%Apr 13, 2026
ActivistOAORBIMED ADVISORS LLC8.8%Apr 10, 2026
InsiderOLORBIMED ADVISORS LLCSell $264KApr 8, 2026
InsiderOLORBIMED ADVISORS LLCSell $205KApr 8, 2026
InsiderOLORBIMED ADVISORS LLCSell $191KApr 7, 2026
InsiderOLORBIMED ADVISORS LLCSell $15KApr 7, 2026
InsiderRLRA CAPITAL MANAGEMENT, L.P.Buy $543KFeb 20, 2026
InsiderRLRA CAPITAL MANAGEMENT, L.P.Buy $535KFeb 19, 2026
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
1.2M(+24.7%)$8.1M0.1%+13.94%
34
Unchanged
626,571$4.3M0.0%+11.35%
0
Increased
381,823(+254.2%)$2.6M0.0%+21.34%
42
New
336,524$2.3M0.0%+25.78%
36
Decreased
313,124(-49.9%)$2.1M0.0%+11.35%
0
Unchanged
274,375$1.9M0.0%+11.35%
0
Decreased
232,591(-4.3%)$1.6M0.0%+11.35%
0
Unchanged
203,799$1.4M0.0%+11.35%
0
Unchanged
184,295$1.3M0.0%+11.35%
0
Increased
101,135(+13.8%)$689,0430.0%+12.92%
19
New
50,334$342,7750.0%+25.78%
33
New
43,666$297,3650.0%+25.78%
32
Decreased
43,106(-70.2%)$293,5520.0%+11.35%
0
Increased
38,368(+910.5%)$261,2860.0%+24.19%
25
New
37,084$252,5420.0%+25.78%
35
Unchanged
36,585$249,1440.0%+11.35%
0
Increased
36,222(+39.9%)$246,6720.0%+15.11%
21
Unchanged
25,000$170,2500.0%+11.35%
0
Increased
19,200(+36.5%)$130,7520.0%+14.87%
20
Increased
19,126(+2.8%)$130,2480.0%+11.70%
23

Showing 1-20 of 35

1 / 2

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used